靶点针对疾病信息20(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
TARGETID
T59679
TARGNAME
5-HT 4 receptor (HTR4)
INDICATI
Approved Digestive system disease [ICD-11: DE2Z]
INDICATI
Approved Dyspepsia [ICD-11: MD92]
INDICATI
Approved Gastro-oesophageal reflux disease [ICD-11: DA22]
INDICATI
Approved Irritable bowel syndrome [ICD-11: DD91]
INDICATI
Phase 2 Gastroduodenal motor/secretory disorder [ICD-11: DA41]
INDICATI
Phase 2 Nausea/vomiting [ICD-11: MD90]
INDICATI
Phase 2 Post-traumatic stress disorder [ICD-11: 6B40]
INDICATI
Phase 2 Supraventricular tachyarrhythmia [ICD-11: BC81]
INDICATI
Phase 1 Heart failure [ICD-11: BD10-BD1Z]
INDICATI
Discontinued in Phase 2 Oesophagus motility disorder [ICD-11: DA21]
INDICATI
Discontinued in Phase 2 Parkinsonism [ICD-11: 8A00]
INDICATI
Investigative Abnormal micturition [ICD-11: MF50]
INDICATI
Investigative General pain disorder [ICD-11: 8E43]
INDICATI
Investigative Neurodegenerative disorder [ICD-11: 8A20-8A23]
INDICATI
Investigative Pain [ICD-11: MG30-MG3Z]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3